|
Real-time
Euronext Paris
12:23:36 28/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.4410 EUR | -6.17% |
|
-21.25% | -62.56% |
| 23/10 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 22/10 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.17% | -21.25% | -39.42% | -47.44% | -62.56% | -60.90% | -55.90% | -88.86% | - | 6.66M | |
| +0.88% | -0.34% | -10.10% | +16.80% | +61.08% | +40.64% | +73.05% | +5.19% | - | 65.28B | |
| -0.56% | -0.56% | -8.15% | -1.77% | +8.23% | +9.18% | +76.48% | +222.71% | +5,402.13% | 54.57B | |
| -0.79% | +0.90% | +7.94% | +12.73% | +17.26% | +8.99% | +100.45% | -16.48% | +256.67% | 53.59B | |
| -2.06% | +2.90% | +1.19% | +31.51% | +21.38% | +24.07% | +48.36% | +6.84% | +274.18% | 45.03B | |
| -1.79% | +0.19% | +2.78% | +13.80% | +22.07% | +19.32% | +123.62% | -3.33% | +1,026.92% | 42.17B | |
| -1.65% | +0.96% | -10.28% | -2.82% | +130.89% | +237.56% | +823.66% | +577.85% | - | 39.42B | |
| -2.26% | -4.14% | +7.10% | +6.98% | +10.22% | +15.38% | +45.53% | +3.86% | +156.29% | 32.71B | |
| -2.70% | -10.77% | -16.37% | +15.52% | +42.05% | +19.80% | -6.47% | -61.99% | - | 24.01B | |
| +0.17% | +13.91% | +28.76% | +55.35% | +46.23% | +58.50% | +47.68% | +2.07% | +159.54% | 26.5B | |
| -1.42% | -2.63% | -11.84% | -2.77% | -8.76% | -17.79% | -10.12% | -70.29% | - | 21.82B | |
| -0.06% | -2.06% | -20.79% | -12.71% | -46.37% | -41.54% | +265.28% | +247.47% | +566.64% | 20.38B | |
| +1.13% | +9.22% | +9.35% | +12.54% | +20.50% | +11.83% | +164.49% | +217.70% | +2,180.99% | 18.93B | |
| +3.45% | +19.08% | +22.00% | +57.68% | +79.10% | +81.32% | +104.07% | -16.88% | +358.10% | 17.06B | |
| -0.63% | +8.08% | +8.46% | +27.59% | +36.83% | +38.65% | +84.49% | -16.62% | +107.33% | 16.69B | |
| +0.90% | +3.88% | +11.95% | +17.59% | +48.55% | +68.16% | +210.20% | +200.60% | +482.38% | 16.13B | |
| +0.73% | +6.61% | +8.67% | -3.43% | - | - | - | - | - | 16.1B | |
| -1.28% | -1.28% | +0.43% | +2.20% | +173.78% | +155.82% | +363.62% | +1,373.64% | +757.63% | 14.75B | |
| -0.80% | +9.30% | +6.64% | +10.87% | +0.86% | +3.18% | -23.60% | -35.55% | +125.72% | 14.18B | |
| -5.62% | -3.16% | -0.44% | -11.74% | +15.55% | +5.49% | +488.95% | - | - | 14.63B | |
| Average | -1.03% | +2.72% | -0.10% | +9.92% | +32.47% | +35.67% | +153.89% | +141.55% | +911.89% | 27.7B | |
| Weighted average by Cap. | -0.78% | +3.09% | +0.23% | +13.08% | +36.78% | +40.85% | +155.87% | +120.99% | +1,220.83% |
- Stock Market
- Stocks
- ALNFL Stock
- Sector NFL Biosciences
Select your edition
All financial news and data tailored to specific country editions
